Crystal structure of dihydrofolate reductase from the emerging pathogenic fungus Candida auris (2023)
- Authors:
- USP affiliated authors: ISHIDA, KELLY - ICB ; DIAS, MARCIO VINÍCIUS BERTACINE - ICB ; BARROSO, VINICIUS DE MORAIS - ICB ; Dias, Vinicius Bertacine - ICB
- Unidade: ICB
- DOI: 10.1107/s2059798323004709
- Subjects: MICROBIOLOGIA; CANDIDA; CANDIDÍASE; ANTIFÚNGICOS; RESISTÊNCIA MICROBIANA ÀS DROGAS; ANTIMETABÓLITOS; CRISTALOGRAFIA ESTRUTURAL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: Wiley-Blackwell Publishing Inc.
- Publisher place: Hoboken
- Date published: 2023
- Source:
- Título: Acta Crystallographica. Section D: Structural Biology
- ISSN: 2059-7983
- Volume/Número/Paginação/Ano: v. 79, (Pt 8), p. 735-745, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
KIRKMAN, Tim et al. Crystal structure of dihydrofolate reductase from the emerging pathogenic fungus Candida auris. Acta Crystallographica. Section D: Structural Biology, v. 79, p. 735-745, 2023Tradução . . Disponível em: https://doi.org/10.1107/s2059798323004709. Acesso em: 09 fev. 2026. -
APA
Kirkman, T., Barroso, M. V. de M., Tosin, M., Dias, V. B., & Ishida, K. (2023). Crystal structure of dihydrofolate reductase from the emerging pathogenic fungus Candida auris. Acta Crystallographica. Section D: Structural Biology, 79, 735-745. doi:10.1107/s2059798323004709 -
NLM
Kirkman T, Barroso MV de M, Tosin M, Dias VB, Ishida K. Crystal structure of dihydrofolate reductase from the emerging pathogenic fungus Candida auris [Internet]. Acta Crystallographica. Section D: Structural Biology. 2023 ; 79 735-745.[citado 2026 fev. 09 ] Available from: https://doi.org/10.1107/s2059798323004709 -
Vancouver
Kirkman T, Barroso MV de M, Tosin M, Dias VB, Ishida K. Crystal structure of dihydrofolate reductase from the emerging pathogenic fungus Candida auris [Internet]. Acta Crystallographica. Section D: Structural Biology. 2023 ; 79 735-745.[citado 2026 fev. 09 ] Available from: https://doi.org/10.1107/s2059798323004709 - Atividade antifúngica de derivados 2-ariloxazolinas e miltefosina sobre Candida spp. e inibição dos fatores de virulência de Candida albicans
- Micobiota e ocorrência de fumonisinas em diferentes genótipos de milho transgênico (Bt)
- 2-aryloxazolines inhibit Candida clinical isolates growth and morphogenesis of Candida albicans and Candida tropicalis
- Integration of biophysical and biological approaches to validate fragment-like compounds targeting l,d-transpeptidases from Mycobacterium tuberculosis
- Novel 2-Aryloxazoline compounds exhibit an inhibitory effect on Candida spp., including antifungal-resistant isolates
- Using a fragment-based approach against a potential novel drug target in Mycobacterium tuberculosis
- Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase
- Structural basis of the selectivity of GenN, an Aminoglycoside N-Methyltransferase involved in gentamicin biosynthesis
- Fragment-Merging strategies with known pyrimidine scaffolds targeting dihydrofolate reductase from mycobacterium tuberculosis
- Mechanistic insights into dideoxygenation in gentamicin biosynthesis
Informações sobre o DOI: 10.1107/s2059798323004709 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
